A new report published by the UK Health Security Agency (UKHSA) and the University of Bristol has found that the NHS England (NHSE) emergency department opt-out testing programme for bloodborne viruses has helped to diagnose thousands of people with serious infections.
Germany-based diagnostic company BIOTYPE has launched a major upgrade of its MODAPLEX platform. The benchtop diagnostic platform for the fully integrated analysis of molecular biomarker signatures allows laboratories in research and clinical settings to perform highly specialised molecular analyses quickly and easily in an automated manner.
Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, has raised £4.3 million in seed funding to develop effective targeted therapeutics against antibiotic-resistant Gram-negative bacteria.
The King Faisal Specialist Hospital and Research Centre (KFSH&RC), in Riyadh, Saudi Arabia, has successfully administered an advanced gene therapy for eight patients suffering from the genetic bleeding disorder haemophilia.
Oxford Nanopore sequencing technology will be used in a pioneering new collaboration with Genomics England, to sequence as many as 7,500 samples from participants of the landmark 100,000 Genomes Project with a range of genetic or suspected genetic disorders.
Finnish company Medix Biochemica, which supplies raw materials to the in vitro diagnostics industry has acquired the US-based ViroStat, a global leader in infectious disease antibodies and antigens. The acquisition significantly expands Medix Biochemica’s portfolio of IVD raw materials, brings complementary scientific capabilities and further strengthens its local presence in the USA.
Beckman Coulter Life Sciences has announced a collaboration agreement with Pillar Biosciences, which develops and distributes IVD and retrospective use (RUO) NGS testing solutions based on its proprietary SLIMamp technology, to help localise patient testing and optimise the selection of precision therapies for cancer patients.
Thousands of patients with heart failure will now be treated from home as the NHS expands its world-leading virtual wards scheme. The expansion means people can remain active and maintain their independence in their own home, while undergoing medical treatment.
Imaging firm Evident has launched the new FLUOVIEW FV4000 confocal laser scanning microscope and FV4000MPE multiphoton laser scanning microscope, designed to redefine scientific imaging by delivering higher precision, reduced noise and improved sensitivity, setting a new standard for image acquisition and data reliability.
Proscia, a leading provider of digital and computational pathology solutions, has earned ISO 27001 certification. This certification demonstrates the company’s compliance with one of the best-known information security management standards, giving customers added confidence in its products.
The government will meet its target to open 160 community diagnostic centres a year early, the Health and Social Care Secretary has announced. All 160 centres will be open by March 2024, a year ahead of the original March 2025 target - speeding up access to diagnostic tests and checks.
PocDoc has been chosen by Roche Diagnostics to participate in the acclaimed Startup Creasphere programme, which will pilot the firm’s cardiovascular diagnostics.
Jade Erwin explains Source LDPath’s new Health Economic Model, and how it can help NHS Trusts and laboratories understand the cost implications and benefits of investing in digital pathology.
Haier Biomedical – a brand synonymous with cold chain storage – has launched a comprehensive range of benchtop centrifuges. Using its extensive knowledge of temperature controlled sample handling and innovative approach to product design, the company has created three benchtop, high-speed refrigerated centrifuges offering industry-leading features.
The Medicines and Healthcare products Regulatory Agency (MHRA) has announced it is taking forward its new ‘regulatory sandbox’, the AI-Airlock, that will provide a regulator-monitored virtual area for developers to generate robust evidence for their advanced technologies.
Four trusts in the Greater Manchester Pathology Network are working to deploy a Clinisys laboratory information management system (LIMS) in a way that will enable them to work more collaboratively and improve services for clinicians and patients. The four trusts will deploy a standardised, interfaced version of WinPath Enterprise to support collaboration and lay the foundation for further innovation.
Diagnostics firm LumiraDx has unveiled a new strategic collaboration with Everton in the Community - the official charity of Everton FC - to set up England’s first community-based heart and lung screening hub, set to go live this month.